Paper41246002
bla IMP-45 Amplification Facilitates Heterogeneous Resistance to Imipenem in Pseudomonas aeruginosa.
Du Y and 7 others. Infect Drug Resist, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. bla IMP-45 Amplification Facilitates Heterogeneous Resistance to Imipenem in Pseudomonas aeruginosa. Papers, record 41246002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41246002
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- bla IMP-45 Amplification Facilitates Heterogeneous Resistance to Imipenem in Pseudomonas aeruginosa.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39234777 | Characterization of the Chromosomally Located Metallo-β-Lactamase Genes blaIMP-45 and blaVIM-2 in a Carbapenem-Resistant Pseudomonas aeruginosa Clinical Isolate. | Microb Drug Resist | 2024 | https://conductscience.org/library/papers/39234777 | PubMed |
| 2 | 8787889 | Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8787889 | PubMed |
| 3 | 39303871 | The frequency of AmpC overproduction, OprD downregulation and OprM efflux pump expression in Pseudomonas aeruginosa: A comprehensive meta-analysis. | J Glob Antimicrob Resist | 2024 | https://conductscience.org/library/papers/39303871 | PubMed |
| 4 | 38730266 | Three concurrent mechanisms generate gene copy number variation and transient antibiotic heteroresistance. | Nat Commun | 2024 | https://conductscience.org/library/papers/38730266 | PubMed |
| 5 | 20110294 | Acquisition of multidrug resistance transposon Tn6061 and IS6100-mediated large chromosomal inversions in Pseudomonas aeruginosa clinical isolates. | Microbiology (Reading) | 2010 | https://conductscience.org/library/papers/20110294 | PubMed |
| 6 | 35572664 | Molecular Mechanism of the β-Lactamase Mediated β-Lactam Antibiotic Resistance of Pseudomonas aeruginosa Isolated From a Chinese Teaching Hospital. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35572664 | PubMed |
| 7 | 39079540 | WHO publishes updated list of bacterial priority pathogens. | Lancet Microbe | 2024 | https://conductscience.org/library/papers/39079540 | PubMed |
| 8 | 39500066 | Multidrug-resistant bacteria quorum-sensing inhibitors: A particular focus on Pseudomonasaeruginosa. | Eur J Med Chem | 2025 | https://conductscience.org/library/papers/39500066 | PubMed |
| 9 | 37879457 | Characterization of a novel Tn6485h transposon carrying both blaIMP-45 and blaAFM-1 integrated into the IncP-2 plasmid in a carbapenem-resistant Pseudomonas aeruginosa. | J Glob Antimicrob Resist | 2023 | https://conductscience.org/library/papers/37879457 | PubMed |
| 10 | 23716048 | Complete sequence of pOZ176, a 500-kilobase IncP-2 plasmid encoding IMP-9-mediated carbapenem resistance, from outbreak isolate Pseudomonas aeruginosa 96. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23716048 | PubMed |
| 11 | 39301190 | Molecular epidemiology and carbapenem resistance mechanisms of Pseudomonas aeruginosa isolated from a hospital in Fujian, China. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39301190 | PubMed |
| 12 | 36651737 | An XDR Pseudomonas aeruginosa ST463 Strain with an IncP-2 Plasmid Containing a Novel Transposon Tn6485f Encoding blaIMP-45 and blaAFM-1 and a Second Plasmid with Two Copies of blaKPC-2. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/36651737 | PubMed |
| 13 | 32243918 | Genomic characterisation of clinical Pseudomonas aeruginosa isolate PAG5 with a multidrug-resistant megaplasmid from China. | J Glob Antimicrob Resist | 2020 | https://conductscience.org/library/papers/32243918 | PubMed |
| 14 | 38515868 | Rates of resistance and heteroresistance to newer β-lactam/β-lactamase inhibitors for carbapenem-resistant Enterobacterales. | JAC Antimicrob Resist | 2024 | https://conductscience.org/library/papers/38515868 | PubMed |
| 15 | 38616963 | Characteristics and phylogenetic distribution of megaplasmids and prediction of a putative chromid in Pseudomonas aeruginosa. | Comput Struct Biotechnol J | 2024 | https://conductscience.org/library/papers/38616963 | PubMed |
| 16 | 39253335 | Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections. | JAC Antimicrob Resist | 2024 | https://conductscience.org/library/papers/39253335 | PubMed |
| 17 | 37457958 | Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/37457958 | PubMed |
| 18 | 33620296 | An IncP-2 plasmid sublineage associated with dissemination of blaIMP-45 among carbapenem-resistant Pseudomonas aeruginosa. | Emerg Microbes Infect | 2021 | https://conductscience.org/library/papers/33620296 | PubMed |
| 19 | 24777897 | IMP-45-producing multidrug-resistant Pseudomonas aeruginosa of canine origin. | J Antimicrob Chemother | 2014 | https://conductscience.org/library/papers/24777897 | PubMed |
| 20 | 31211681 | Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015. | Emerg Infect Dis | 2019 | https://conductscience.org/library/papers/31211681 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42045833 | Genomic characterization of the multidrug-resistant IncP-2 plasmid pPAMS in a clinical isolate Pseudomonas aeruginosa. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/42045833 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41246002
GET https://conductscience.org/api/papers/v1/41246002/references?page=2